More high-impact data, in more tools, to help more researchers: CiteAb and Springer Nature expand partnership
5
Min Read
In this blog:
- Discover how CiteAb has expanded their successful partnership with Springer Nature
- How is CiteAb data being integrated into protocols.io
- Learn how the growing partnership helps researchers and suppliers
With millions of reagents on the market from hundreds of suppliers, choosing the right product is a complex, time-consuming and high-stakes decision.
There is a mammoth cost to time, precious samples and budget associated with irreproducible research, largely driven by ineffective reagents. [1,2]
To help address this challenge, today we’re excited to announce the expansion of our partnership with Springer Nature.
Together, we are transforming high-quality, full-text publication content into actionable, easy-to-access reagent insights to help scientists find reliable tools, faster.
A Growing Collaboration Between CiteAb and Springer Nature
In 2022, we announced our partnership with Springer Nature.
Springer Nature are a household name in quality publishing, with the largest collection of research methods in the Springer Protocols books and with journals including Nature, Nature Reviews Molecular Cell Biology and Nature Biotechnology, to name but a few.
Through our initial partnership, CiteAb gained access to Springer Nature Protocols and Methods content. This content was fed into our world-class data mining pipeline, which to date has extracted over 150,000 reagent citations and significantly reduced the time it takes to unlock insights from these high impact publications.
Since then, we’ve been working closely together to find new ways to bring value to the research community. For example, in 2023, CiteAb data was integrated into the Springer Nature Experiments platform.
Now, we are excited to build on our partnership further. CiteAb will analyse Springer Nature’s complete life science portfolio, with hundreds of thousands of additional publications.
This step will massively increase the volume of high-quality reagent usage data available to the global research community.
How our Expanded Data Partnership Works in Practice
CiteAb will analyse Springer Nature’s trusted publication portfolio using our industry-leading data collection pipeline, which combines AI-driven text mining with expert human review. This will generate contextualised information on how reagents have been used in scientific publications.
Data collected includes applications, species reactivity, validation data, and more – curated from free-text and tables into a structured, searchable format. This insight would otherwise require thousands of hours of manual literature review to collect.
We then feed this data back into:
- CiteAb research tools for scientists and pharma companies
- CiteAb’s data services for suppliers
- Springer Nature, for internal use
- The protocols.io platform, part of Springer Nature
Learn more about each application below:
Feeding Knowledge Back Into CiteAb Search Tools and Data Licensing for Pharma/Biotech Companies
Structured reagent data from our partnership is fed into the CiteAb Explore platform, strengthening both our Reagent Search and Image Search tools.
For researchers, this added reagent information will help with:
- Faster identification of reliable reagents
- Reducing wasted research budgets and precious patient samples
- Improving experimental reproducibility
With over 95,000+ scientists using CiteAb Explore, this new data will reach a significant amount of scientists evaluating reagents for their work.
You can try out the CiteAb Explore platform and see Springer Nature’s high-quality structured data in action here!
We also license our reagent data for internal use in AI tools and workflows to pharma and biotech companies, to streamline and de-risk reagent selection. High-quality Springer Nature data will enhance the insights provided.
New data supports citation provision and market data services
Through our plug-in web tool, the Widget, suppliers can show highly accurate reagent citations on their webpages, to help researchers make more informed decisions and build product credibility.
Quantitative reagent data we collect also powers our market data services, which support more informed product development, targeted sales & marketing and impactful strategy.
Our expanded partnership puts us in a unique position to provide a greater depth of insight to suppliers using these services.
Learn more about our data services here: Data services for reagent suppliers
Structured reagent data integrated into protocols.io
Through our partnership, Springer Nature are also able to unlock insights from their full-text content and create new value for researchers.
In a new step, structured data will be integrated into the protocol.io platform.
protocols.io is a secure platform for developing and sharing reproducible methods. Reagent data can be used for streamlined data entry, making it possible for scientists to select products when entering protocols.
This ensures standardisation across protocols, making it easier for scientists to reproduce experiments, and saves time.
Example screenshot of reagent data from CiteAb used in the protocols.io platform
Additionally, the protocols.io platform is rolling out advanced new capabilities to help life scientists better design and troubleshoot experiments. Multilingual protocol translations, prompt-to-protocol draft creation, and AI-powered troubleshooting are just some of the functionalities that the CiteAb’s data will significantly boost.
President and Founder of protocols.io, Dr. Lenny Teytelman said:
“Starting in 2013 for CiteAb and 2014 for protocols.io, the fledgling efforts both focused on improving research reproducibility. For a decade, the founders collaborated and exchanged notes as both initiatives matured and grew. And today, it is particularly exciting to extend the verbal collaboration into the above-described explicit partnership with benefits for the researchers using CiteAb and protocols.io!”
Future Outlook
By combining Springer Nature’s trusted scientific content with CiteAb’s data mining tech and reagent search tools, this partnership will help researchers worldwide access reliable experimental insights, accelerate discovery, and improve research outcomes.
CiteAb CEO, Dr Andrew Chalmers, said;
“Springer Nature share our love of science and are impressive innovators with tools like protocols.io. We have really enjoyed working closely with the team for many years and we feel closely aligned on our mission to provide high quality information to help inform scientists worldwide. This news represents a major step forward, allowing us to unlock a significantly larger volume of valuable insights. Thank you to the team at Springer Nature for their work on this exciting partnership! ”
Director of Product Management for Experimental Workflow Solutions, Dr. Robin Padilla said:
“Years ago, when Springer Nature and CiteAb first connected, we had a desire to serve the life science community by creating a valuable and durable long-term partnership. It’s been a wonderful experience working with CiteAb. It’s even more exciting now that we can both deepen and broaden our efforts to support and boost successful experiments.“
We are excited to continue building on our partnership with Springer Nature and seeing what new innovation we can create together to help the research community.
References
[1] https://pmc.ncbi.nlm.nih.gov/articles/PMC4461318/
[2] https://pubmed.ncbi.nlm.nih.gov/37995198/
